Your session is about to expire
← Back to Search
Behavioral Intervention
care.coach Pilot for Bone Marrow Transplant
N/A
Waitlist Available
Led By Gregory Abel, MPH, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights
Study Summary
This trial will test if an avatar-based technology can improve outcomes for people admitted to the hospital for a transplant.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Modification of care.coach
Patient Retention
Secondary outcome measures
Patient Satisfaction Rate
Rate of Completion of the HCT Educational Modules
The Completion Rate Post-Pilot Survey
Trial Design
1Treatment groups
Experimental Treatment
Group I: care.coach PilotExperimental Treatment1 Intervention
The research study procedures include screening for eligibility, a brief call with a research assistant after tablet is given to subject, and a survey after a subject has completed the study.
3 consecutive cohorts of 6 RIC HCT patients each.
care.coach is a "human-in the-loop" conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates. A subject uses the avatar for up to 3 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Care.Coach
2022
N/A
~20
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,079 Previous Clinical Trials
340,930 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,658 Previous Clinical Trials
40,924,471 Total Patients Enrolled
Gregory Abel, MPH, MDPrincipal InvestigatorDana-Farber Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have undergone a reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (HCT).Only certain healthcare professionals (such as DFCI/HCC HCT nurse navigators, inpatient HCT nurses, and HCT doctors and extenders) are allowed to participate in the study.You must be 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: care.coach Pilot
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open opportunities to enroll in this study?
"Affirmative. Clinicaltrials.gov's data implies that this research project, which was initially posted on November 1st 2022 is currently recruiting participants. 18 individuals need to be enrolled from two separate medical centres."
Answered by AI
What is the participation rate of this experiment?
"Affirmative. According to the information published on clinicaltrials.gov, this medical trial is still actively enrolling patients as of November 21st 2022 - an edit from its initial posting date of November 1st. A total of 18 individuals will be accepted across 2 different sites."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger